Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport-Reference-Cited by-同舟云学术

Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport

Published:2017-06-30 Issue:3 Volume:9 Page:035001
ISSN:1758-5090
Container-title:Biofabrication
language:
Short-container-title:Biofabrication

Author:

van Wenum Martien,Treskes Philipp,Tang Chung-Yin,Coppens Esmee J,Jansen Koen,Hendriks Erik J,Camus Sandrine,van Gulik Thomas M,Chamuleau Robert A F M,Hoekstra Ruurdtje

Funder

Seventh Framework Programme

Publisher

IOP Publishing

Subject

Biomedical Engineering,General Medicine,Biomaterials,Biochemistry,Bioengineering,Biotechnology

Link

https://iopscience.iop.org/article/10.1088/1758-5090/aa7657/pdf

Reference21 articles.

1. Phase I Clinical Trial with the AMC-Bioartificial Liver

2. Liver Support Therapy: An Overview of the AMC-Bioartificial Liver Research

3. Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver Failure

4. Artificial and bioartificial liver devices: present and future

5. Evaluation of Encapsulated Liver Cell Spheroids in a Fluidised-Bed Bioartificial Liver for Treatment of Ischaemic Acute Liver Failure in Pigs in a Translational Setting

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic effects of low-level sodium arsenite exposure on human liver HepaRG cells;Archives of Toxicology;2020-08-25

2. HepaRG Self-Assembled Spheroids in Alginate Beads Meet the Clinical Needs for Bioartificial Liver;Tissue Engineering Part A;2020-06-01

3. Advanced Biomaterials and Processing Methods for Liver Regeneration: State‐of‐the‐Art and Future Trends;Advanced Healthcare Materials;2020-01-24

4. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Disrupts Control of Cell Proliferation and Apoptosis in a Human Model of Adult Liver Progenitors;Toxicological Sciences;2019-09-19

5. Fibrosis in tissue engineering and regenerative medicine: treat or trigger?;Advanced Drug Delivery Reviews;2019-06